• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨骼肌指数对经动脉化疗栓塞后肝细胞癌栓塞后综合征的影响。

Effect of skeletal muscle index on post-embolization syndrome of hepatocellular carcinoma after transarterial chemoembolization.

机构信息

Hebei Provincial Key Laboratory of Portal Hypertension and Cirrhosis, Xingtai People's Hospital, Xingtai, Hebei, 054001, China.

Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

出版信息

BMC Gastroenterol. 2024 Sep 30;24(1):333. doi: 10.1186/s12876-024-03427-0.

DOI:10.1186/s12876-024-03427-0
PMID:39350028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11441167/
Abstract

BACKGROUND

Skeletal muscle index (SMI) is a commonly used research method for evaluating muscle mass.However, its impact on post-embolization syndrome(PES) of patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE) is unclear.Our objective was to determine the effect of SMI on PES after TACE in patients with HCC.

METHODS

We conducted a retrospective analysis of patients who received TACE treatment for HCC at our hospital from 2015 to 2020. The subjects were divided into two groups according to the presence or absence of PES after TACE, and their clinical characteristics were compared.SMI was measured and calculated by cross-sectionally at the level of the third lumbar vertebra based on computed tomography (CT). According to the cutoff value, the patients were classified into either low or high SMI group.Potential risk factors for PES were assessed using univariate and multivariable Cox proportional risk models.

RESULTS

A total of 110 people were included in this study, from which including 82 patients experienced PES. Serum albumin was significantly lower in the PES group compared to the non-PES group.The frequency of HCC with a maximum diameter > 3 cm and low SMI in the PES group was significantly higher than in patients without PES. Cox multivariate analysis identified that the maximum diameter of HCC > 3 cm and low SMI were independent predictors of PES after TACE.

CONCLUSIONS

Low SMI is an independent predictor of PES in HCC patients after TACE treatment, making preoperative CT assessment of skeletal muscle mass is a simple and effective tool for predicting PES.

摘要

背景

骨骼肌指数(SMI)是评估肌肉量的常用研究方法。然而,其对接受经动脉化疗栓塞术(TACE)治疗的肝细胞癌(HCC)患者的栓塞后综合征(PES)的影响尚不清楚。我们的目的是确定 SMI 对 HCC 患者 TACE 后 PES 的影响。

方法

我们对 2015 年至 2020 年在我院接受 TACE 治疗的 HCC 患者进行了回顾性分析。根据 TACE 后是否发生 PES,将患者分为两组,并比较其临床特征。SMI 通过 CT 横断位在第三腰椎水平进行测量和计算。根据截断值,将患者分为低 SMI 组或高 SMI 组。使用单变量和多变量 Cox 比例风险模型评估 PES 的潜在危险因素。

结果

本研究共纳入 110 人,其中 82 人发生 PES。与非 PES 组相比,PES 组的血清白蛋白显著降低。在 PES 组中,HCC 最大直径>3cm 和低 SMI 的发生率明显高于无 PES 组。Cox 多变量分析确定 HCC 最大直径>3cm 和低 SMI 是 TACE 后 PES 的独立预测因素。

结论

低 SMI 是 HCC 患者 TACE 治疗后 PES 的独立预测因素,提示术前 CT 评估骨骼肌量是预测 PES 的一种简单有效的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71e/11441167/1b5acec0e493/12876_2024_3427_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71e/11441167/441c7e9f898d/12876_2024_3427_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71e/11441167/1b5acec0e493/12876_2024_3427_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71e/11441167/441c7e9f898d/12876_2024_3427_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c71e/11441167/1b5acec0e493/12876_2024_3427_Fig2_HTML.jpg

相似文献

1
Effect of skeletal muscle index on post-embolization syndrome of hepatocellular carcinoma after transarterial chemoembolization.骨骼肌指数对经动脉化疗栓塞后肝细胞癌栓塞后综合征的影响。
BMC Gastroenterol. 2024 Sep 30;24(1):333. doi: 10.1186/s12876-024-03427-0.
2
CT-based skeletal muscle loss for predicting poor survival in patients with hepatocellular carcinoma experiencing curative hepatectomy plus adjuvant transarterial chemoembolization: a preliminary retrospective study.基于 CT 的骨骼肌丢失预测接受根治性肝切除加辅助经动脉化疗栓塞治疗的肝细胞癌患者生存不良的初步回顾性研究。
Eur J Med Res. 2022 Jul 25;27(1):131. doi: 10.1186/s40001-022-00760-6.
3
Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.骨骼肌量迅速下降预示经导管肝动脉内治疗的肝细胞癌预后不良。
BMC Cancer. 2018 Jul 24;18(1):756. doi: 10.1186/s12885-018-4673-2.
4
Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization.影响首次经导管肝动脉化疗栓塞术治疗肝细胞癌患者栓塞后综合征的因素。
J Cancer Res Ther. 2021 Jul;17(3):777-783. doi: 10.4103/jcrt.jcrt_132_21.
5
Post-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma.栓塞后综合征作为肝细胞癌经动脉化疗栓塞术后总生存的早期预测指标
HPB (Oxford). 2015 Dec;17(12):1137-44. doi: 10.1111/hpb.12487. Epub 2015 Sep 16.
6
Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization.低腰大肌指数与经动脉化疗栓塞治疗的肝细胞癌患者生存率降低相关。
Ann Med. 2022 Dec;54(1):1562-1569. doi: 10.1080/07853890.2022.2081872.
7
Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.不可切除肝细胞癌患者经载药微球与传统经动脉化疗栓塞治疗后的影像学改变及临床并发症:多中心研究。
AJR Am J Roentgenol. 2021 Oct;217(4):933-943. doi: 10.2214/AJR.20.24708. Epub 2020 Nov 27.
8
Computed Tomography Perfusion Following Transarterial Chemoembolization of Hepatocellular Carcinoma: A Feasibility Study in the Early Period.肝细胞癌经动脉化疗栓塞术后的计算机断层扫描灌注:早期可行性研究
J Comput Assist Tomogr. 2017 Sep/Oct;41(5):708-712. doi: 10.1097/RCT.0000000000000592.
9
Computed tomography radiomic features and clinical factors predicting the response to first transarterial chemoembolization in intermediate-stage hepatocellular carcinoma.基于 CT 影像组学特征与临床因素预测中期肝细胞癌患者首次经动脉化疗栓塞治疗反应的研究
Hepatobiliary Pancreat Dis Int. 2024 Aug;23(4):361-369. doi: 10.1016/j.hbpd.2023.06.011. Epub 2023 Jul 5.
10
Imaging Predictors of Survival in Patients with Single Small Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.经动脉化疗栓塞术治疗单个小肝细胞癌患者的生存影像学预测因子。
Korean J Radiol. 2021 Feb;22(2):213-224. doi: 10.3348/kjr.2020.0325. Epub 2020 Aug 28.

引用本文的文献

1
Clinical predictors for liver function impairment and post-embolization syndrome following transcatheter arterial chemoembolization in primary hepatic carcinoma patients: a retrospective study.原发性肝癌患者经动脉化疗栓塞术后肝功能损害和栓塞后综合征的临床预测因素:一项回顾性研究
Am J Cancer Res. 2025 May 15;15(5):2259-2274. doi: 10.62347/PJVG6340. eCollection 2025.

本文引用的文献

1
Frailty and sarcopenia in patients with cirrhosis awaiting liver transplantation: evidence from a single-centre, prospective cohort study.肝硬化患者在等待肝移植时的虚弱和肌肉减少症:一项单中心前瞻性队列研究的证据。
Updates Surg. 2024 Sep;76(5):1807-1818. doi: 10.1007/s13304-024-01962-9. Epub 2024 Aug 5.
2
The prognostic nutritional index as a predictor of efficacy and early recurrence for adjuvant transarterial chemoembolization in hepatocellular carcinoma.预后营养指数作为预测肝癌辅助经动脉化疗栓塞疗效和早期复发的指标。
Clin Res Hepatol Gastroenterol. 2024 Jun;48(6):102344. doi: 10.1016/j.clinre.2024.102344. Epub 2024 Apr 18.
3
Effect of Sarcopenia on the Prognosis of Clinical Outcomes in Patients With Hepatocellular Carcinoma After Hepatic Resection.
肌肉减少症对肝癌肝切除术后患者临床结局预后的影响。
Am Surg. 2024 Jun;90(6):1447-1455. doi: 10.1177/00031348241241713. Epub 2024 Mar 22.
4
Non-invasive assessment of response to transcatheter arterial chemoembolization for hepatocellular carcinoma with the deep neural networks-based radiomics nomogram.基于深度学习的放射组学列线图无创评估肝细胞癌经导管动脉化疗栓塞治疗的疗效。
Acta Radiol. 2024 Jun;65(6):535-545. doi: 10.1177/02841851241229185. Epub 2024 Mar 15.
5
Development of a predictive nomogram for postembolization syndrome after transcatheter arterial chemoembolization of hepatocellular carcinoma.经导管动脉化疗栓塞术治疗肝细胞癌后栓塞后综合征预测列线图的构建。
Sci Rep. 2024 Feb 8;14(1):3303. doi: 10.1038/s41598-024-53711-y.
6
Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy.肌肉减少症对接受介入治疗联合免疫治疗及靶向治疗的肝细胞癌患者的预后影响
J Hepatocell Carcinoma. 2024 Jan 24;11:175-189. doi: 10.2147/JHC.S444530. eCollection 2024.
7
Correlation between sarcopenia and cirrhosis: a meta-analysis.肌肉减少症与肝硬化之间的相关性:一项荟萃分析。
Front Nutr. 2024 Jan 10;10:1342100. doi: 10.3389/fnut.2023.1342100. eCollection 2023.
8
The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients.肌肉减少症和肌肉脂肪变性对经动脉(化疗)栓塞治疗 HCC 患者的预测价值。
Aging (Albany NY). 2024 Jan 5;16(1):389-401. doi: 10.18632/aging.205375.
9
Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis.经肝动脉化疗栓塞术治疗肝细胞癌后综合征的预测及其对预后的影响。
Hepatol Commun. 2023 Sep 27;7(10). doi: 10.1097/HC9.0000000000000252. eCollection 2023 Oct 1.
10
Prognostic value of preoperative prealbumin levels in patients with unresectable hepatocellular carcinoma undergoing transcatheter arterial chemoembolisation.术前前白蛋白水平对不可切除肝细胞癌患者经动脉化疗栓塞术的预后价值
Heliyon. 2023 Jul 20;9(8):e18494. doi: 10.1016/j.heliyon.2023.e18494. eCollection 2023 Aug.